Intravenous immunoglobulin in the treatment of resistant subacute cutaneous lupus erythematosus: a possible alternative

Clin Rheumatol. 2007 Jun;26(6):981-3. doi: 10.1007/s10067-006-0222-5. Epub 2006 May 3.

Abstract

Subacute cutaneous lupus erythematosus (SCLE) is a common manifestation of systemic lupus erythematosus. In many cases it appears to be resistant to various systemic or topical treatments. Three cases of resistant SCLE with good response to intravenous immunoglobulin (IVIG) are described here suggesting that IVIG could be an alternative treatment in these patients.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Female
  • Humans
  • Immunoglobulins, Intravenous / therapeutic use*
  • Immunologic Factors / therapeutic use*
  • Lupus Erythematosus, Discoid / drug therapy*
  • Treatment Outcome

Substances

  • Immunoglobulins, Intravenous
  • Immunologic Factors